Inhibition of Glutamine Uptake Improves the Efficacy of Cetuximab on Gastric Cancer

Treatment for advanced gastric cancer is challenging. Epidermal growth factor receptor (EGFR) contributes to the proliferation and development of gastric cancer (GC), and its overexpression is associated with unfavorable prognosis in GC. Cetuximab, a monoclonal antibody targeting EGFR, failed to imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Huanrong, Wu, Jingjing, Zhou, Minyu, Wu, Jianhua, Wu, Zhenzhen, Lin, Li, Huang, Na, Liao, Wangjun, Sun, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488517/
https://www.ncbi.nlm.nih.gov/pubmed/34590499
http://dx.doi.org/10.1177/15347354211045349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488517/
https://www.ncbi.nlm.nih.gov/pubmed/34590499
http://dx.doi.org/10.1177/15347354211045349

Ejemplares similares